| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |